| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/18/2001 | US20010032016 Method for in vitro production of bone |
| 10/18/2001 | US20010032015 In vitro modification of cardiac valvular xenografts |
| 10/18/2001 | US20010031256 Vision defects |
| 10/18/2001 | US20010031253 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 10/18/2001 | US20010031252 Endogenous immune response |
| 10/18/2001 | CA2406045A1 Method for producing a nematocidal composition by heat treating a ph-adjusted fermentation broth |
| 10/18/2001 | CA2405912A1 Albumin fusion proteins |
| 10/18/2001 | CA2405870A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 10/18/2001 | CA2405806A1 A method to prevent graft rejection using tgf-.beta. to induce t suppressor cells |
| 10/18/2001 | CA2405181A1 Human pyruvate dehydrogenese phosphatase |
| 10/18/2001 | CA2405151A1 Bile acid containing prodrugs with enhanced bioavailability |
| 10/18/2001 | CA2404634A1 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof |
| 10/18/2001 | CA2404313A1 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| 10/18/2001 | CA2404265A1 Human ovarian mesothelial cells and methods of isolation and uses thereof |
| 10/17/2001 | EP1146125A1 Poxvirus with targeted infection specificity |
| 10/17/2001 | EP1146118A1 Organs for transplantation induced in vitro |
| 10/17/2001 | EP1146117A1 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus |
| 10/17/2001 | EP1145720A2 A high-mineral oyster extract and a process for manufacturing the same |
| 10/17/2001 | EP1145013A2 Removal of prions from blood, plasma and other liquids |
| 10/17/2001 | EP1145001A2 (in vitro) model for gastrointestinal inflammation |
| 10/17/2001 | EP1144998A2 Neisseria genomic sequences and methods of their use |
| 10/17/2001 | EP1144671A2 Enriched central nervous system cell populations |
| 10/17/2001 | EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 10/17/2001 | EP1144634A2 Novel complex-forming proteins |
| 10/17/2001 | EP1144633A1 Polypeptide |
| 10/17/2001 | EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 10/17/2001 | EP1144623A1 Method and medicament for inhibiting the expression of a defined gene |
| 10/17/2001 | EP1144621A2 Genetic suppressor elements against human immunodeficiency virus |
| 10/17/2001 | EP1144614A2 33 human secreted proteins |
| 10/17/2001 | EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 10/17/2001 | EP1144596A2 Application of shear flow stress to smooth muscle cells for the production of implantable structures |
| 10/17/2001 | EP1144595A2 Platform for the differentiation of cells |
| 10/17/2001 | EP1144594A1 Transgenic circulating endothelial cells |
| 10/17/2001 | EP1144591A2 Low oxygen culturing of cells |
| 10/17/2001 | EP1144313A1 Method for activating water and use of activated water of this type |
| 10/17/2001 | EP1144015A1 Treating protein-containing liquids |
| 10/17/2001 | EP1144009A2 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 10/17/2001 | EP1144005A1 Treatment of papillomavirus infections |
| 10/17/2001 | EP1143995A1 Anti-dandruff composition comprising an antifungal polypeptide |
| 10/17/2001 | EP1143994A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
| 10/17/2001 | EP1143985A2 Use of lactobacillus salivarius |
| 10/17/2001 | EP1143984A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 10/17/2001 | EP1143983A1 Spray delivery of cells |
| 10/17/2001 | EP1143982A2 Method for preparing membrane vesicles |
| 10/17/2001 | EP1143927A2 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
| 10/17/2001 | EP1143797A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 10/17/2001 | CN1318105A Methods for down-regulating osteoprotegerin ligand activity |
| 10/17/2001 | CN1317973A Prepns. for immunotherapy for cancer having bacterial somatic constituent as active ingredient |
| 10/17/2001 | CN1317327A Medicinal wine for treating rheumatic and rheumatoid diseases and its preparing prcess |
| 10/17/2001 | CN1317321A Medicine for treating intractable ischias and chronic lumbocrural pain and its preparing process |
| 10/17/2001 | CN1072959C Medicine for treating gastritis, gastric ulcer and duocenal ulcer and its prepn. method |
| 10/17/2001 | CN1072958C Pancreas-recovering thirst-relieving and blood sugar reducing powder, and preparing method thereof |
| 10/17/2001 | CN1072956C Health oral liquid and its prepn. method |
| 10/17/2001 | CN1072955C Tonic liquid of black ewe's placenta extract and its preparing method |
| 10/17/2001 | CN1072950C Traditional Chinese medicinal powder for treating oral diseases, and method for preparing same |
| 10/17/2001 | CN1072949C Medicine for treating anorexia |
| 10/17/2001 | CN1072948C Process for preparing Chinese medicine 'Buxueyimu' particles |
| 10/17/2001 | CN1072947C Medicine for curing waist sprain and contusion |
| 10/17/2001 | CN1072946C Diabetes treating medicine |
| 10/17/2001 | CN1072940C Oral liquid for anti-cancer and its prepn. method |
| 10/17/2001 | CN1072939C Medicament for treating primary glomerular disease |
| 10/17/2001 | CN1072938C Traditional chinese medicine for curing gastric disease |
| 10/17/2001 | CN1072937C Oral liquid for giving up drug |
| 10/17/2001 | CN1072936C Medicine for curing cerebrovascular, cardiovascular and peripheral vascular diseases |
| 10/16/2001 | US6303580 Cyclitol Containing carbohydrates from human tissue which regulate lipogenic activity |
| 10/16/2001 | US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis |
| 10/16/2001 | US6303375 Apparatus for aggregation propagation; for use in treatment of liver; for use as artificial liver |
| 10/16/2001 | US6303355 Method of culturing, cryopreserving and encapsulating pancreatic islet cells |
| 10/16/2001 | US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy |
| 10/16/2001 | US6303161 Foods, feeds, cosmetics, drugs |
| 10/16/2001 | US6303154 Colltecting urine from a mammal, treating with oxidizing agent and a gas atmosphere of oxygen in a container, adding protease and incubating; removing substances with low molecular weight to yeild modified urine |
| 10/16/2001 | US6303152 Taking body fluids from a person suffering illeness; desaggregating the body fluids by reducing the body fluids to sub-cell size substances by cell lysis; exposing to oxygen or ozone or ultraviolet radiation |
| 10/16/2001 | US6303151 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 10/16/2001 | US6303120 Inducing antibodies in a subject to an allyl-substituted pentasaccharide by administering the compound conjugated to a protein carrier at its allyl group. |
| 10/16/2001 | US6303112 Enriched platelet wound healant |
| 10/16/2001 | CA2181156C Macroencapsulated secretory cells |
| 10/12/2001 | CA2305062A1 Compositions for and method of treatment for psoriasis |
| 10/11/2001 | WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | WO2001075110A2 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | WO2001075094A1 Application of myeloid-origin cells to the nervous system |
| 10/11/2001 | WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 10/11/2001 | WO2001075072A2 PRODUCTION OF TcR GAMMA DELTA T CELLS |
| 10/11/2001 | WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF |
| 10/11/2001 | WO2001074900A2 Nuclear factor kb inducing factor |
| 10/11/2001 | WO2001074859A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 10/11/2001 | WO2001074855A2 Compositions and methods for dendritic cell-based immunotherapy |
| 10/11/2001 | WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 10/11/2001 | WO2001074491A2 Eggshell waste processing method and device |
| 10/11/2001 | WO2001074413A1 Medical devices suitable for gene therapy regimens |
| 10/11/2001 | WO2001074404A2 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor |
| 10/11/2001 | WO2001074382A1 Method of treatment using ligand-immunogen conjugates |
| 10/11/2001 | WO2001074377A1 Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy |
| 10/11/2001 | WO2001074164A1 Methods of modulating hair growth |
| 10/11/2001 | WO2001049317A3 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 10/11/2001 | WO2001036640A3 Human fgf-21 gene and gene expression products |
| 10/11/2001 | WO2001031003B1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 10/11/2001 | WO2001021765A3 METHOD FOR THE SELECTIVE PROTECTION OF PROLIFERATING NORMAL CELLS AND THE SELECTIVE ERADICATION OF TUMOR CELLS HAVING AN INACTIVE p53 PATHWAY |
| 10/11/2001 | WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 10/11/2001 | WO2001020025A3 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 10/11/2001 | WO2000042429A3 In vitro model for gastrointestinal inflammation |